Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.

@article{Gomes2014IncidenceDO,
  title={Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.},
  author={Marisa Zenaide Ribeiro Gomes and Victor Eduardo Mulanovich and Ying Jiang and Russell E Lewis and Dimitrios P Kontoyiannis},
  journal={Antimicrobial agents and chemotherapy},
  year={2014},
  volume={58 2},
  pages={865-73}
}
Although primary antifungal prophylaxis (PAP) is routinely administered in patients with acute myeloid leukemia (AML) during remission-induction and consolidation chemotherapy, the impact of PAP on the incidence of invasive fungal infections (IFIs) is not well described. We retrospectively analyzed the incidence of IFIs in 152 patients with AML who had been… CONTINUE READING